Prescribing, Recording and Reporting of BNCT
In this chapter, recommendations for prescribing, recording and especially reporting of dose in BNCT are developed and discussed. The main goal of the authors was that these recommendations are coherent with the general rules of prescribing, recording and
- PDF / 231,063 Bytes
- 9 Pages / 439.37 x 666.14 pts Page_size
- 56 Downloads / 216 Views
15
Jürgen Rassow and Wolfgang A.G. Sauerwein
Contents 15.1 Aim of Prescribing, Recording and Reporting ........................................................... 278 15.2 Problem of Dose Specification for BNCT in Comparison to Conventional Photon and Electron Therapy ...................................................................................... 279 15.3 Uncertainties for Evaluation and Biological Weighting of Dose Components ........ 280 15.4 Resulting Recommendations on Prescribing, Recording and Reporting ................ 282 References ................................................................................................................................. 284
J. Rassow NCTeam, Department of Radiation Oncology, Former Institute for Medical Radiation Physics, University Duisburg-Essen, University Hospital Essen, D-45259, Essen, Germany e-mail: [email protected] W.A.G. Sauerwein (*) NCTeam, Department of Radiation Oncology, University Hospital Essen, University Duisburg-Essen, D-45122, Essen, Germany e-mail: [email protected] W.A.G. Sauerwein et al. (eds.), Neutron Capture Therapy, DOI 10.1007/978-3-642-31334-9_15, © Springer-Verlag Berlin Heidelberg 2012
277
278
15.1
J. Rassow and W.A.G. Sauerwein
Aim of Prescribing, Recording and Reporting
When a malignant disease of a patient is presented for radiotherapy, three documentation steps are required: before the start, prescribing; during the course of therapy, recording; and after finishing, writing the final report (reporting). • Prescribing is the first step for the radiation oncologist, where he identifies the patient, describes the disease including the anamnestic data and fixes the aim of the radiotherapy, the method and concept of the treatment and the facility to be used. For BNCT, this includes any details on pretreatment operations, the 10B carrier and the required 10B concentration in blood at the time of radiotherapy. The therapist has to detail the planning target volume and the regions at risk and at least the minimum and maximum absorbed dose in the clinical target volume and the maximum tolerable absorbed dose in the organs at risk. The radiation oncologist prescribes the mode of treatment planning, mostly with dose-volume histograms, based on computer tomography and decides which of the treatment plans is the best and to be chosen. He also decides whether field verification and in vivo dosimetry should be applied and which additional actions, e.g. simulator, or support, e.g. for positioning, is necessary. Information on the (medical) staff present, date of prescription and signature are obligatory. • Recording is the second step, performed mainly during the radiotherapy itself. As well as the name of the hospital, the therapy facility, identification of the patient, the realised treatment plan and treated clinical target volumes, all details of the treatment are to be recorded, such as dates of each fraction, geometrical and dosimetrical settings of the facility, actual 10B concentrations at the beginning and th
Data Loading...
